[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.147.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 570
Citations 0
Correction
Aug 2012

Error in Text. in: Effect of a Single-Cycle Alternative Dosing Regimen for Rituximab for Recalcitrant Pemphigus: A Case Series of 9 Patients

Arch Dermatol. 2012;148(8):970. doi:10.1001/archdermatol.2012.2872

Error in Text. In the Observation titled “Effect of a Single-Cycle Alternative Dosing Regimen for Rituximab for Recalcitrant Pemphigus: A Case Series of 9 Patients” by Matsukura et al, published in the June issue of the Archives (2012;148[6]:734-739), an error occurred in the text on page 734. In the second paragraph of the “Introduction,” the fourth sentence should have read, “In contrast, rituximab has been approved7,9 for rheumatoid arthritis at a dosage of 1000 mg on days 1 and 15.”

×